IL94081A - Receptors for mass-interferon-gamma, their production and pharmaceutical preparations containing them - Google Patents

Receptors for mass-interferon-gamma, their production and pharmaceutical preparations containing them

Info

Publication number
IL94081A
IL94081A IL9408190A IL9408190A IL94081A IL 94081 A IL94081 A IL 94081A IL 9408190 A IL9408190 A IL 9408190A IL 9408190 A IL9408190 A IL 9408190A IL 94081 A IL94081 A IL 94081A
Authority
IL
Israel
Prior art keywords
receptor
plasmid
ifn
fragment
protein
Prior art date
Application number
IL9408190A
Other languages
English (en)
Hebrew (he)
Other versions
IL94081A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL94081A0 publication Critical patent/IL94081A0/xx
Publication of IL94081A publication Critical patent/IL94081A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL9408190A 1989-04-19 1990-04-13 Receptors for mass-interferon-gamma, their production and pharmaceutical preparations containing them IL94081A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89810295 1989-04-19

Publications (2)

Publication Number Publication Date
IL94081A0 IL94081A0 (en) 1991-01-31
IL94081A true IL94081A (en) 1996-09-12

Family

ID=8203144

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9408190A IL94081A (en) 1989-04-19 1990-04-13 Receptors for mass-interferon-gamma, their production and pharmaceutical preparations containing them

Country Status (11)

Country Link
EP (1) EP0393502B1 (fr)
JP (1) JPH02303490A (fr)
AT (1) ATE132191T1 (fr)
AU (1) AU625866B2 (fr)
CA (1) CA2014752A1 (fr)
DE (1) DE69024398T2 (fr)
DK (1) DK0393502T3 (fr)
IE (1) IE901373L (fr)
IL (1) IL94081A (fr)
NZ (1) NZ233308A (fr)
ZA (1) ZA902843B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88378A (en) * 1988-11-14 2000-11-21 Yeda Res & Dev Human interferon-gamma binding proteins their manufacture and pharmaceutical compositions comprising them
IL91562A0 (en) * 1989-09-07 1990-04-29 Yeda Res & Dev Interferon-gamma receptor fragment and its production
CA2081309A1 (fr) * 1990-04-24 1991-10-25 Paul J. Zavodny Recepteurs solubles tronques du gamma-interferon
AU5669694A (en) * 1992-11-20 1994-06-22 Schering Corporation Antagonists of human gamma interferon
US6558661B1 (en) 1992-12-29 2003-05-06 Genentech, Inc. Treatment of inflammatory bowel disease with IFN-γ inhibitors
CA2114168A1 (fr) * 1993-03-05 1994-09-06 Zlatko Dembic Polypeptides humains chimeriques derives du recepteur de l'interferon gamma et d'immunoglobulines
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
US20020025316A1 (en) 1995-08-18 2002-02-28 Ferguson Mark Williams James Pharmaceutical composition containing inhibitors of interferon-gamma
WO1997019110A1 (fr) * 1995-11-23 1997-05-29 Cancer Research Campaign Technology Limited Materiaux et procedes relatifs a l'identification et au sequençagge du gene de susceptibilite brca2 du cancer et ses utilisations
US7020843B2 (en) 1999-11-30 2006-03-28 Uhc Llc Method and system for implementing a browser object container
US6606103B1 (en) 1999-11-30 2003-08-12 Uhc Llc Infinite resolution scheme for graphical user interface object
CU23229A1 (es) * 2002-05-10 2007-09-26 Ct Ingenieria Genetica Biotech ANTAGONISTA QUIMéRICO ANTH1
US7608430B2 (en) 2005-07-08 2009-10-27 Regeneron Pharmaceuticals, Inc. Interferon-γ antagonists and therapeutic uses thereof
GB0624071D0 (en) * 2006-12-01 2007-01-10 Bioline Res Ltd Purification methods and materials

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78444A (en) * 1986-04-08 1992-05-25 Yeda Res & Dev Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody

Also Published As

Publication number Publication date
ZA902843B (en) 1990-12-28
DK0393502T3 (da) 1996-03-04
CA2014752A1 (fr) 1990-10-19
IE901373L (en) 1990-10-19
AU5309390A (en) 1990-11-08
IL94081A0 (en) 1991-01-31
JPH02303490A (ja) 1990-12-17
NZ233308A (en) 1992-11-25
DE69024398T2 (de) 1996-06-13
DE69024398D1 (de) 1996-02-08
ATE132191T1 (de) 1996-01-15
EP0393502A1 (fr) 1990-10-24
EP0393502B1 (fr) 1995-12-27
AU625866B2 (en) 1992-07-16

Similar Documents

Publication Publication Date Title
EP0393502B1 (fr) Récepteurs solubles de l'interféron gamma ainsi que leurs méthodes de production
US5932448A (en) Bispecific antibody heterodimers
US5712121A (en) Chimeric interleukin 5-receptor/immunoglobulin polypeptides
FI93025C (fi) Rekombinantti lymfotoksiini
AU603775B2 (en) Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid
Brothers et al. Characterization of a surface antigen of Eimeria tenella sporozoites and synthesis from a cloned cDNA in Escherichia coli
IL105271A (en) Tumor nectosis factor and variants
CA2264200A1 (fr) Endokine alpha humaine
CA2084514A1 (fr) Interferon-alpha o-glycosyle
EP0439535B1 (fr) Adnc codant pour la sous unite gamma du recepteur de grande affinite pour l'immunoglobuline e
US5496926A (en) Process of preparing a soluble LDL receptor
CA2058003A1 (fr) Recepteur d'interleukine-5 humaine
Van Mellaert et al. Efficient secretion of biologically active mouse tumor necrosis factor α by Streptomyces lividans
Jacobson et al. Expression and secretion of biologically active echistatin in Saccharomyces cerevisiae
EP0315118A2 (fr) ADN codant pour endothéline et son utilisant
AU593118B2 (en) Polypeptide competitor for immunoglobulin e
CA2087494C (fr) Recepteur soluble ldl, fabrication et utilisation de celui-ci
EP0676413B1 (fr) Protéine liant l'interféron alpha/bêta, sa production et son application
KR100688051B1 (ko) 각질세포-유래된 인터페론
AU702379B2 (en) Novel feline cytokine protein
EP0614981A1 (fr) Chimères humaines récepteur de l'interféron gamma/immunoglobuline
US20040053249A1 (en) Fas ligand-fused proteins
Murata et al. Production of poly (L-aspartyl-L-phenylalanine) in Escherichia coli
CA3237004A1 (fr) Inhibiteurs doubles de facteur d'activation des lymphocytes b (baff)-ligand a induisant la proliferation (april)
JP3130338B2 (ja) ポリペプチドおよびその製造法

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void